Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
INR 24.21
(-0.62%)
INR 24.21
(-0.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 108.92 Million | -421.15 Million | 117.76 Million | 340.79 Million | -320.95 Million | 25.24 Million |
| Net Income | -222.67 Million | -96.87 Million | -242.07 Million | -142.03 Million | -73.73 Million | -79.58 Million |
| Depreciation & Amortization | 1.99 Million | 2.12 Million | 2.36 Million | 2.36 Million | 2.76 Million | 4.13 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 268.36 Million | -377.01 Million | -415 Thousand | 442.06 Million | -247.59 Million | 103 Million |
| Other non-cash items | 61.23 Million | 50.6 Million | 357.89 Million | 38.39 Million | -2.38 Million | -2.31 Million |
| Investing Cash Flow | 4.62 Million | 5.31 Million | 6.68 Million | 9.12 Million | 6.98 Million | 9.63 Million |
| Investments in PPE | -29.32 Million | - | -5000.00 | -5000.00 | -251 Thousand | -22 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4.62 Million | 5.31 Million | 6.69 Million | 9.12 Million | 7.23 Million | 9.65 Million |
| Financing Cash Flow | -147.11 Million | 450 Million | -122.03 Million | -344.14 Million | 307.07 Million | -7.89 Million |
| Debt repayment | -76.66 Million | -505.91 Million | -291.83 Million | -291.83 Million | -322.22 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -70.44 Million | 955.91 Million | 169.8 Million | -52.3 Million | 629.29 Million | -7.89 Million |
| Accounts receivables | -127.43 Million | -11.22 Million | 553.58 Million | 553.58 Million | -570.27 Million | -94.9 Million |
| Accounts payables | -3.87 Million | -139.23 Million | -6.52 Million | -6.52 Million | 437.66 Million | 1.3 Million |
| Inventory | 348.27 Million | -227.59 Million | 382.28 Million | -372.79 Million | -127.17 Million | -13.5 Million |
| Other working capital | 51.39 Million | 1.04 Million | -929.75 Million | 267.8 Million | 12.19 Million | 210.1 Million |
| Cash at beginning of period | 46.43 Million | 12.27 Million | 9.85 Million | 4.07 Million | 11.97 Million | 3.1 Million |
| Cash at end of period | 12.85 Million | 46.43 Million | 12.27 Million | 9.85 Million | 4.07 Million | 11.97 Million |
| Capital Expenditure | -29.32 Million | - | -5000.00 | -5000.00 | -251 Thousand | -22 Thousand |
| Effect of forex changes on cash | 1000.00 | -1000.00 | -7000.00 | - | -997 Thousand | -18.1 Million |
| Net cash flow / Change in cash | -33.57 Million | 34.16 Million | 2.42 Million | 5.77 Million | -7.89 Million | 8.87 Million |
| Free Cash Flow | 79.6 Million | -421.15 Million | 117.76 Million | 340.78 Million | -321.2 Million | 25.22 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -49.18 Million | -45.87 Million | -222.67 Million | -42.93 Million | -46.83 Million | -30.83 Million |
| Depreciation & Amortization | 343 Thousand | 343 Thousand | 1.99 Million | 364 Thousand | 365 Thousand | 365 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 268.36 Million | - | - | - |
| Other non-cash items | -343 Thousand | -343 Thousand | 61.23 Million | -364 Thousand | -365 Thousand | -365 Thousand |
| Investing Cash Flow | - | - | 4.62 Million | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | -147.11 Million | - | - | - |
| Debt repayment | - | - | -76.66 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -70.44 Million | - | - | - |
| Accounts receivables | - | - | -127.43 Million | - | - | - |
| Accounts payables | - | - | -3.87 Million | - | - | - |
| Inventory | - | - | 348.27 Million | - | - | - |
| Other working capital | - | - | 51.39 Million | - | - | - |
| Cash at beginning of period | 63.76 Million | 12.85 Million | 46.43 Million | 55.79 Million | 1.76 Million | 32.59 Million |
| Cash at end of period | 14.58 Million | -45.87 Million | 12.85 Million | 12.85 Million | -46.83 Million | 1.76 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 1000.00 | - | - | - |
| Net cash flow / Change in cash | -49.18 Million | -58.73 Million | -33.57 Million | -42.93 Million | -48.6 Million | -30.83 Million |
| Free Cash Flow | -49.18 Million | -45.87 Million | 108.92 Million | -42.93 Million | -46.83 Million | -30.83 Million |
MITSU
PFMT
PAYO
9068
ENB-PT
SHIP